13/06/2019 10:00:00

Payveris Closes $7M Series D Round

CROMWELL, Conn., June 13, 2019 (GLOBE NEWSWIRE) -- Payveris LLC, the fastest-growing provider of digital money movement technology to financial institutions, announced the completion of the company’s Series D funding round to accelerate client acquisition, platform innovation and the scale-up of the organization as the company continues its rapid growth.

Silicon Valley-based Mosaik Partners, which led the Series C round, also led the Series D.  All other institutional investors in the Series C participated in the Series D, including Black Dragon Capital, Connecticut Innovations and Ironwood Capital.  A top 20 credit union joined the round as a strategic investor in Payveris.

“We are delighted that our existing investors and our new strategic partner are convinced the company will maintain its high-growth trajectory,” said Ron Bergamesca, Payveris CEO. “The additional funding will allow us to significantly expand our investment in platform development, organizational infrastructure and sales and marketing initiatives to further solidify our position as the premier provider to progressive financial institutions determined to take control of their digital payments destiny, while simplifying and modernizing their money movement infrastructure.”

David Dame, Payveris’ board chairman commented, “Since Ron and the rest of current executive team joined Payveris, the company has performed at a very high level, now providing innovative payment services to over 240 financial institutions, including the recent signings of a top 100 bank and a top 20 credit union and securing an investment from another top 20 credit union.  With the current leadership team, the board is confident the company will continue to gain significant market share.”

Howard Mergelkamp, Managing Partner at Mosaik Partners added, “We led the Series C because of the potential we saw in Payveris. The company’s recent track record of strong performance confirmed our investment thesis and compelled us to also lead the Series D round.  We are excited about where the company is heading and look forward to even more success in the future.”

About Payveris

Payveris is the creator of The MoveMoney Platformsm, an Open API cloud-based platform enabling financial institutions to control, simplify + extend digital money movement capabilities to any application/device while lowering user experience friction, significantly reducing operating costs & future-proofing the IT investment. Shift from a product-centric digital payments model to a platform-centric model today! Visit

www.payveris.com

to learn more.

MEDIA CONTACTS:

Chris Spicer

Payveris

cspicer@payveris.com

860-372-4108

Payveris Logo

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
20 Jun
 
I øjeblikket sidder "vinderne" ved folketingsvalget og forhandler regeringsgrundlag. De er enige om ..
44
18 Jun
 
Ingen grund til at flytte, de fleste har ikke råd, det er altid middelklassen det rammer og alligeve..
34
20 Jun
 
Måske jeg er den eneste, men savner Alpehue og hans gode indlæg... er han her under et andet alias? ..
23
23 Jun
 
Kære Nets-formand, du er i Danmark, ikke USA Vi er et samfund, hvor få har for meget og færre for li..
20
21 Jun
VELO
Mangel på to tacrolimus - konvertere pat. til Envarsus   I USA konvertere de patienter til Envarsus ..
20
21 Jun
 
@ckt - synes egentlig det havde vaeret bedre, du ikke havde skrevet noget overhovedet..
20
19 Jun
OMXC25
  De vil aldrig få penge nok. Jeg vil tro, at der aldrig er tilført de offentlige kasser flere penge..
20
20 Jun
CHEMM
ChemoMetec opjusterer forventningerne til omsætningen og driftsresultatet som følger af højere forve..
19
21 Jun
VELO
Ser ud til at man omkring 1 juli starter et nyt forsøg op med Envarsus hvor man tilsyneladende forve..
17
18 Jun
AMBU-B
Jeg er rigtig tilfred med de udmeldinger JJG kommer med idag. Det giver ro over deres udmeldinger, o..
17

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
2
Global Arena Holding Inc. (GAHC), Files First Quarter 10Q, and Updates Shareholders on Subsidiaries
3
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Eros International Plc (NYSE: EROS) and Encourages Eros Investors to Contact the Firm
4
Hofseth Biocare ASA: Signed Letter of Intent with Garden of Life® for exclusive use of CollaGo® and ProGo® in the US market
5
Final Data Analysis of Phase 2 PBC Trial Shows that Genkyotex’s Anti-fibrotic Candidate GKT831 Demonstrated Statistically Significant Improvements in GGT and ALP Over Full Treatment Period

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 June 2019 23:29:44
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-25 00:29:44 - 2019-06-24 23:29:44 - 1000 - Website: OKAY